Rchr
J-GLOBAL ID:201901006539969297
Update date: Sep. 04, 2024
Takashi Yahata
ヤハタ タカシ | Takashi Yahata
Affiliation and department:
Job title:
Professor
Research field (3):
Immunology
, Tumor biology
, Hematology and oncology
Research theme for competitive and other funds (19):
- 2023 - 2027 Elucidation of stem cell motility mechanism and its application to regeneration and cancer therapy
- 2021 - 2025 線溶系制御因子を標的とした新規複合的がん免疫療法の確立
- 2020 - 2022 Development of novel genome editing tool for gene therapy and its application to cancer therapy
- 2018 - 2021 An analysis for development of myelodysplastic syndrome and influence of ROS
- 2017 - 2021 Analysis of interraction of multiple myeloma cells and bone marrow stroma cells using xenograft models
- 2016 - 2018 The exploration of new drug for the treatment of Notch-active tumor cells.
- 2015 - 2018 Blockade of PAI-1 eliminates leukemic stem cells
- 2014 - 2017 Maintenance of bone homeostasis by DLL1-mediated Notch activation
- 2012 - 2015 Establishment of hematopoietic regeneration by the novel molecular targeting drug
- 2012 - 2015 In vivo analysis of gene mutations related to epigenetic alterations in acute myeloid leukemia
- 2010 - 2015 Development of experimentation systems related to personalized medicine using humanized NOG mice
- 2011 - 2013 Analysis of Multiple myeloma pahtophysiology using xenograft model having humanized BM microenvironment
- 2010 - 2011 DNA damage response in human hematopoietic stem cell
- 2009 - 2011 Genetic abnormality require their specific differentiation stage in leukemogenensis
- 2008 - 2010 Identification of molecular mechanisms that link bone remodeling and hematopoietic homeostasis
- 2008 - 2009 Analysis of repopulating dynamics of human hematopoietic stem cells
- 2006 - 2007 Molecular mechanism of leukemica stem cells maintenance in vivo
- 2006 - 2007 Establishment of human hematopoietic system model mouse for understanding the regulatory mechanisms of human hematopoiesis.
- 2005 - 2006 Establishment of a novel in vivo model of human leukemia
Show all
Papers (63):
-
Abd Aziz Ibrahim, Taku Fujimura, Tomoko Uno, Tomoya Terada, Ken-ichi Hirano, Hiroyuki Hosokawa, Akio Ohta, Toshio Miyata, Kiyoshi Ando, Takashi Yahata. Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1. Frontiers in Immunology. 2024. 15
-
Kaito Harada, Takashi Yahata, Makoto Onizuka, Takamasa Ishii, Abd Aziz Ibrahim, Eri Kikkawa, Yoichi Gondo, Kiyoshi Ando. Mitochondrial Electron Transport Chain Complex II Dysfunction Causes Premature Aging of Hematopoietic Stem Cells. Stem cells (Dayton, Ohio). 2023. 41. 1. 39-49
-
Shohei Kawakami, Mitsuyo Tsuma-Kaneko, Masakazu Sawanobori, Tomoko Uno, Yoshihiko Nakamura, Hideyuki Matsuzawa, Rikio Suzuki, Makoto Onizuka, Takashi Yahata, Kazuhito Naka, et al. Pterostilbene downregulates BCR/ABL and induces apoptosis of T315I-mutated BCR/ABL-positive leukemic cells. Scientific reports. 2022. 12. 1. 704-704
-
Ken-Ichi Hirano, Hiroyuki Hosokawa, Takashi Yahata, Kiyoshi Ando, Masayuki Tanaka, Jin Imai, Masaki Yazawa, Masato Ohtsuka, Naoko Negishi, Sonoko Habu, et al. Dll1 Can Function as a Ligand of Notch1 and Notch2 in the Thymic Epithelium. Frontiers in immunology. 2022. 13. 852427-852427
-
Ken-Ichi Hirano, Hiroyuki Hosokawa, Maria Koizumi, Yusuke Endo, Takashi Yahata, Kiyoshi Ando, Katsuto Hozumi. LMO2 is essential to maintain the ability of progenitors to differentiate into T-cell lineage in mice. eLife. 2021. 10
more...
MISC (7):
-
今井仁, 今井仁, 八幡崇, 田中里佳, 金子元基, 水上創, 中原史雄, 市川仁志, 稲垣豊, 稲垣豊, et al. Suppress Intestinal Fibrosis in Crohn’s Disease by Fibrinolytic System Adjustment. 潰瘍. 2020. 47. 91-96
-
片平 泰弘, 樋口 廣士, 山本 雄一郎, 安藤 潔, 幸谷 愛, 松下 弘道, 八幡 崇, 小池 亮, 佐藤 克明, 今留 謙一, et al. Increased Granulopoiesis in the Bone Marrow following Epstein-Barr Virus Infection(和訳中). 東京医科大学雑誌. 2020. 78. 3. 290-291
-
Daisuke Harama, Minori Tamai, Takeshi Inukai, Kumiko Goi, Takashi Yahata, Kiyoshi Ando, Takumi Ito, Hiroshi Handa, Kanji Sugita. Lenalidomide Effectively Induces Philadelphia-Chromosome Positive ALL Cells into Apoptosis in Synergy with Tyrosine Kinase Inhibitor. BLOOD. 2016. 128. 22
-
Natsuko Yamakawa, Ken-Ichi Imadome, Takashi Yahata, Ai Kotani. MODULATION OF MACROPHAGES BY TUMOR-DERIVED SECRETARY SMALL RNAS IS CRITICAL FOR EBV POSITIVE LYMPHOMA FORMATION. EXPERIMENTAL HEMATOLOGY. 2015. 43. 9. S102-S102
-
Hiromichi Matsushita, Takashi Yahata, Yin Sheng, Yoshihiko Nakamura, Yukari Muguruma, Hideyuki Matsuzawa, Masayuki Tanaka, Hideki Hayashi, Tadayuki Sato, Anar Damdinsuren, et al. In Vivo Analysis of PML-RARA in a Humanized Mouse Model. BLOOD. 2014. 124. 21
more...
Patents (2):
Return to Previous Page